National Institutes of Health
1981 articles about National Institutes of Health
-
Portland-based Children's Cancer Therapy Development Institute is discovering more targeted drugs for childhood cancers and driving them into clinical development with industry partner Artisan Biopharma.
-
Following reports that Pfizer has declined study requests for Paxlovid, the company and NIH are said to be in conversation about potential studies assessing a longer treatment period of the antiviral.
-
Avrobio presented clinical data on Tuesday at the 25th Annual Meeting of the American Society for Gene and Cell Therapy (ASGCT) from its trial of AVR-RD-04, and preliminary results are promising.
-
Moderna responded to claims that the government should be co-patent owners of the mRNA vaccine developed by the company and said its mRNA sequence was exclusively selected by Moderna scientists.
-
New data continues to emerge that seems to add to the possibility of COVID-19 originating from a lab leak at China’s Wuhan Institute of Virology.
-
Viewpoint Molecular Targeting(TM) Awarded $5 Million in Phase II SBIR Grants from the National Institutes of Health - National Cancer Institute
1/19/2021
- $2 million Phase II SBIR grant awarded to advance image-guided alpha-particle therapy for metastatic melanoma and radioisotope production technologies - Second year of a $2 million Phase II SBIR funding to begin a Phase 1 clinical imaging trial of complementary Pb-203 and Ga-68 diagnostics for metastatic melanoma - $2 million Phase II Small Business Innovation Research (SBIR) grant awarded to fund development activities and advance preclinical studies of VMT-
-
Syntegra Partnering with National Institutes of Health (NIH) and the Bill and Melinda Gates Foundation to Democratize Access to the Largest Set of COVID-19 Patient Records
1/18/2021
Today Syntegra and the National Institutes of Health (NIH) have announced a collaboration to validate Syntegra's AI-enabled synthetic data technology to advance the understanding of and care for COVID-19. Using Sy
-
It has been thought that llamas may hold the key to developing an effective therapeutic against COVID-19, as well as the flu. This morning, scientists from the National Institutes of Health made additional headway in llama research, isolating promising antibodies from the South American animal.
-
Research Roundup: Huntington’s Mutation Linked to Frontotemporal Dementia and ALS and More
12/11/2020
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones. -
Matinas BioPharma Announces Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate Oral Formulations of Gilead’s Antiviral Remdesivir Utilizing Matinas’ LNC Platform Delivery Technology
12/7/2020
Matinas BioPharma Holdings, Inc. announced that they plan to collaborate with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to test oral formulations of remdesivir in preclinical models.
-
Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study
11/16/2020
Moderna intends to submit for an Emergency Use Authorization (EUA) with U.S. FDA in the coming weeks and expects the EUA to be based on the final analysis of 151 cases and a median follow-up of more than 2 months
-
Annovis Bio Reports Positive Results from Final Phase of $1.9M NIH Funded Chronic Toxicology Study for its Lead Compound for the Treatment of Alzheimer’s and Parkinson’s Diseases
11/12/2020
Annovis Bio Inc. announced it successfully completed the dog cohort of a chronic toxicology study of its lead therapeutic compound ANVS401 for the treatment of AD and PD, reporting no negative side effects.
-
Children’s Hospital Los Angeles Surgeon Establishes First-Ever Guidelines for Pediatric Opioid Prescribing
11/11/2020
Children’s Hospital Los Angeles surgeon, Lorraine Kelley-Quon, MD, forms team of health care providers and community advocates to establish recommendations for safe opioid use
-
Seven Bridges Announces Participation in NIH INCLUDE Project Data Coordinating Center
11/5/2020
Collaboration across leading academic institutions and industry to create data coordinating center to advance understanding of Down syndrome and its co-occurring medical conditions
-
NIH Award Funds Data Coordinating Center for Down Syndrome Research
11/5/2020
The new initiative will fuel collaboration and discovery about the biology of Down syndrome and its co-occurring medical conditions
-
CND Life Sciences Awarded NIH SBIR Grant to Advance Diagnostic Technology for Neurodegenerative Diseases
10/26/2020
Grant Supports the Continued Validation and Enhancement of the Syn-One Test™ To Help Physicians Diagnose Parkinson's Disease and Other Serious Disorders
-
Dovel Subsidiary, Medical Science & Computing LLC (MSC) Awarded Specialized and Strategic Services to Support the National Institutes of Health (NIH) Intramural Research Program (IRP)
10/22/2020
Dovel Technologies announced that their subsidiary Medical Science & Computing LLC has been awarded an IDIQ contract worth a potential of $105M to support the National Institutes of Health Intramural Research Program.
-
New Study from NIH Finds Nicotinamide Riboside Helps Improve Telomere Dysfunction in Human Cells, Mice
10/19/2020
New preclinical study finds boosting NAD+ with nicotinamide riboside alleviated telomere damage, providing protective effect to DNA strands
-
Surrozen Awarded NIH Grant to Support Development of SZN-043, a Liver-Specific Regenerative Antibody, for the Treatment of Severe Alcoholic Hepatitis
10/15/2020
Surrozen Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies, has been awarded an NIH grant to support development of SZN-043, a novel liver-targeted regenerative antibody.
-
Visby Medical's Personal PCR Receives Funding from National Institute of Health, RADx Program
10/13/2020
Visby Medical™, an infectious disease diagnostic company, received Phase 2 funding from the National Institutes of Health (NIH) as part of its Rapid Acceleration of Diagnostics (RADx) initiative. The RADx initiative aims to combat SARS-CoV-2 and increase national testing capacity for COVID-19.